Eczema cream showdown: steroid vs Non-Steroid in kids
NCT ID NCT07537751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two creams for mild to moderate eczema in 40 children aged 1-12. One cream was a steroid (fluticasone), the other a non-steroid (crisaborole). Both were applied twice daily for 6 weeks, then twice weekly for 12 weeks if the skin improved a lot. Both treatments worked well; the steroid worked faster, but the non-steroid showed a trend toward keeping eczema away longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Crisaborole 2% ointment and fluticasone propionate 0.05% cream
What this could lead to
If successful, this could show that crisaborole is a good non-steroid option for children with eczema, possibly with fewer relapses than steroid creams.
What could go wrong
This was a small, completed trial with only 40 children, so results may not apply to all patients. The trend toward fewer relapses with crisaborole needs confirmation in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine, Kafr Elsheikh University
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt